Mycophenolate Sodium bulk supplier for pharma manufacturers

Mycophenolate Sodium 180mg , 360 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 180mg , 360 mg

Reference Brands: Myfortic®(EU&US)

Mycophenolate sodium 180 mg and 360 mg gastro-resistant tablets, an immunosuppressant used after kidney transplantation. For importers, distributors, transplant centres and hospital tender buyers needing registered generic supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Mycophenolate Sodium? List it or send an offer →

Product Description:

Mycophenolate sodium is an immunosuppressant. Once absorbed it releases mycophenolic acid, which blocks inosine monophosphate dehydrogenase. Lymphocytes depend on that enzyme to make purines, so their proliferation is held back. This page covers 180 mg and 360 mg gastro-resistant (delayed-release) tablets. The enteric coat keeps the drug intact in the stomach and releases it in the small intestine.

Its main approved use is prophylaxis of acute rejection after kidney transplantation in adults, given twice daily alongside ciclosporin and corticosteroids. Tablets are swallowed whole and never crushed or split. A 720 mg dose of the sodium salt delivers roughly the same mycophenolic acid as 1 g of mycophenolate mofetil, yet the two are not swapped milligram for milligram without a prescriber's review. The drug is teratogenic, so strict pregnancy prevention and contraception rules apply. Blood counts are checked regularly, infection and skin cancer risks rise, live vaccines are avoided, and magnesium or aluminium antacids reduce absorption.

Sourcing notes. This is a prescription-only transplant medicine, and many hospital pharmacies handle it as a hazardous drug, so an intact coating matters. Request a CTD or ACTD dossier with bioequivalence data and a two-stage dissolution profile showing acid resistance followed by release in buffer. For hot, humid destinations ask for Zone IVb stability at 30 °C/75% RH. Moisture-tight blisters at room temperature are usual. Each consignment should carry batch CoAs, plus the GMP certificate and a CoPP. Your enquiry should state the strengths, pack size, destination market and whether a pregnancy-prevention leaflet in the local language is required.

Mycophenolate Sodium — third party manufacturing & bulk supply

Mycophenolate Sodium 180mg , 360 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Mycophenolate Sodium is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Mycophenolate Sodium listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Mycophenolate Sodium →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Mycophenolate Sodium is listed as Tablet in 180mg , 360 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Mycophenolate Sodium is referenced against Myfortic®(EU&US). Reference brands are shown for identification only and remain the property of their respective trademark owners.